Michael Mackett - Concepedia

Author

Michael Mackett

Cancer Research UK Manchester Institute

Also Known As

MICHAEL MACKETT, Michael Mackett

Publications

Citations

H-Index

Concepts

All Affiliations

Cancer Research UK Manchester Institute National Institute of Allergy and Infectious Diseases The University of Texas Health Science Center at San Antonio

About

Michael Mackett is an author at Cancer Research UK Manchester Institute specializing in medicine, vaccination, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	810
2	Immunology	5	5	810
3	Cell Biology	2	2	233
4	Microbiology	1	1	420
5	Cell Signaling	1	1	30

Michael Mackett

Publications

965

Citations

H-Index

Page 1

	Year	Citations
Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen Geoffrey L. Smith, Michael Mackett, Bernard Moss Nature VaccinationVaccine DevelopmentViral HepatitisImmunologyHepatitis B	1983	420
Vaccinia Virus Recombinant Expressing Herpes Simplex Virus Type 1 Glycoprotein D Prevents Latent Herpes in Mice Kenneth J. Cremer, Michael Mackett, Charles Wohlenberg, Science VaccinationMolecular VirologyVaccine DevelopmentSynthetic VirologyNeurovirology	1985	203
Anti‐viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia‐recombinant virus expressing LCMV‐WE nucleoprotein or glycoprotein Manuela Hany, Stephan Oehen, Manfred Schulz, European Journal of Immunology Viral PathogenesisImmunologyAntigen ProcessingImmunotherapyGp Specificity	1989	123
TRANSFERRIN RECEPTOR-MEDIATED GENE TRANSFER TO THE CORNEAL ENDOTHELIUM1 Peng Tan, William J. King, Daxin Chen, Transplantation	2001	46
The Epstein-Barr Virus Candidate Vaccine Antigen gp340/220 Is Highly Conserved between Virus Types A and B Janice F. Lees, Jane E. Arrand, Stuart D Pepper, Virology VaccinationVaccine DevelopmentImmunologyHighly ConservedVirology	1993	34
Vaccinia expression of secreted proteins: tissue plasminogen activator signal sequence enhances expression and immunogenicity of Ag85 Adam Malin, Kris Huygen, Jean Content, Microbes and Infection VaccinationMucosal VaccinationVaccine DevelopmentVaccine ResearchVaccine Target	2000	30
Epidemiology of Herpesvirus Papio Infection in a Large Captive Baboon Colony: Similarities to Epstein‐Barr Virus Infection in Humans Hal B. Jenson, Yasmin Ench, Shou‐Jiang Gao, The Journal of Infectious Diseases	2000	28
Recombinant Vaccinia Viruses Protect Against <i>Clostridium perfringens</i> α-Toxin Alice M. Bennett, T. Lescott, R.J. Phillpotts, Viral Immunology	1999	26
MHC class II-restricted presentation of endogenously synthesized antigen: Epstein-Barr virus transformed B cell lines can present the viral glycoprotein gp340 by two distinct pathways Steven P. Lee, Lesley E. Wallace, Michael Mackett, International Immunology	1993	20
Characterization of an Epstein–Barr virus-related gammaherpesvirus from common marmoset (Callithrix jacchus) Hal B. Jenson, Yasmin Ench, Yan‐Jin Zhang, Journal of General Virology	2002	19

Page 1